Mannatech (NASDAQ:MTEX) Releases Earnings Results

Mannatech (NASDAQ:MTEX) posted its quarterly earnings results on Thursday. The company reported $4.61 earnings per share (EPS) for the quarter, FiscalAI reports. The firm had revenue of $24.87 million for the quarter. Mannatech had a negative return on equity of 2,383.34% and a negative net margin of 6.90%.

Mannatech Price Performance

NASDAQ MTEX traded down $2.12 during trading on Friday, reaching $6.86. The company’s stock had a trading volume of 16,348 shares, compared to its average volume of 25,954. The stock has a market capitalization of $13.24 million, a PE ratio of -1.75 and a beta of 0.62. The firm has a fifty day moving average of $8.02 and a 200 day moving average of $6.35. Mannatech has a one year low of $3.80 and a one year high of $9.97.

Analyst Upgrades and Downgrades

MTEX has been the topic of a number of recent research reports. Wall Street Zen upgraded Mannatech to a “buy” rating in a report on Saturday, November 7th. Weiss Ratings upgraded Mannatech from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, October 29th. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.

Mannatech Company Profile

Mannatech, Incorporated develops and markets nutritional supplements, health and wellness products, and personal-care products through a direct-selling business model. Its product offerings have included dietary supplements, functional nutrition products, weight-management formulas, and skin-care products, with an emphasis on ingredients intended to support general wellness and healthy aging. The company is best known for its Ambrotose product line, which incorporates plant-sourced polysaccharides, as well as related nutritional supplements and wellness programs.